TP53 and cancer: We characterized most frequently affected cancer signalling pathways in MSS SBA, focusing on mutations in known pathways—Wnt/β-catenin, TGF-β, PI3K/AKT, ERBB, ERK/MAPK, and p53 signalling (S6 Table).